14 completed, 4 unknown, 2 withdrawn. 9 Not applicable, 6 Phase 1, 5 Phase 2, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 9 | Completed 6, Unknown 2, Withdrawn 1 |
| Phase 1 | 6 | Completed 5, Withdrawn 1 |
| Phase 2 | 5 | Completed 3, Unknown 2 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow stearic acid: new trials by email Literature Review of stearic acid trials Research Report on stearic acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efect Supplementation Vitamin D in Diabetes Mellitus Type 2 Vitamin D 5000 IU+ placebo, Placebo : calcium carbonate 500 mg, microcrystalline cellulose, magnesium stearate, sodium starch glycolate - Diabetes Mellitus Type 2 (T2DM) | Not applicable | Completed | Trisakti University | 92 | 2024-08-06 | 2025-06-13 |
| GS-441524 for COVID-19 SAD, FE, and MAD Study in Healthy Subjects GS-441524, Placebo - COVID-19 | Phase 1 | Withdrawn | National Center for Advancing Translational Sciences (NCATS) | 2024-06-15 | 2025-02-14 | |
| Efficacy of Vaginal 17β-Estradiol on the Urinary Storage Symptoms in Postmenopausal Women vaginal 17 beta-estradiol, Placebo, Behavioral modifications - Lower Urinary Tract Symptoms, Female Genitourinary Disease | Phase 4 | Completed | Mahidol University | 86 | 2024-04-08 | 2025-04-20 |
| NBMI Treatment in Patients With Mercury Toxicity (N1, N3-bis(2- mercaptoethyl)isophthalamide), Excipients microcrystalline cellulose, silica and magnesium stearate - Mercury Poisoning | Phase 2 / Phase 3 | Unknown | EmeraMed | 116 | 2023-11-22 | 2024-03-12 |
| Melatonin and Zinc Administration on Cardinal Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome melatonin plus zinc, isomaltose and magnesium stearate - Chronic Fatigue Syndrome, Myalgic Encephalomyelitis | Not applicable | Unknown | Laboratorios Viñas, S.A. | 106 | 2022-09-05 | 2022-07-12 |
| Study Design of the Diacerein in Patients With Covid-19 Diacerein, placebo capsules - COVID-19 | Phase 2 | Unknown | University of Campinas, Brazil | 40 | 2022-04-01 | 2022-08-02 |
| A Randomized Phase 1 of of MZE001 in Healthy Volunteers MZE001, Placebo - Healthy | Phase 1 | Completed | Maze Therapeutics | 121 | 2022-02-07 | 2023-02-06 |
| Efficacy of Probiotics in Reducing Duration and Symptoms of COVID-19 Probiotics (2 strains 10x10^9 UFC), Placebo (potato starch and magnesium stearate) - COVID-19 | Not applicable | Completed | Centre de recherche du Centre hospitalier universitaire de Sherbrooke | 17 | 2021-01-12 | 2021-10-29 |
| Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion Fucoxanthin, Placebo - Metabolic Syndrome | Phase 2 | Completed | University of Guadalajara | 28 | 2019-09-30 | 2024-11-21 |
| Assessing the Effect of Shatavari Supplementation on Bone and Skeletal Muscle Health in Healthy Postmenopausal Women Shatavari, Magnesium stearate - Muscle Weakness, Osteoporosis, Postmenopausal | Not applicable | Completed | University of Exeter | 24 | 2019-04-16 | 2021-08-30 |
| A Counter Measure for the Effects of Immune and Microbiome Changes in Environments With Limited ANtigen Diversity (ICELAND-TWO) Bifidobacterium longum 1714, placebo sachet containing maltodextrin and magnesium stearate. - Confinement and Isolation | Not applicable | Unknown | University Hospital Tuebingen | 40 | 2018-11-15 | 2018-11-19 |
| Impact of Oral Probiotic Blend on Pregnancy Outcome capsule containing a probiotic blend of 5 different Lactobacilli, capsule containing Microcrystalline Cellulose, Magnesium Stearate, Silicon Dioxide, but no probiotics. - Gestational Diabetes Mellitus in Pregnancy | Not applicable | Completed | i-Health, Inc. | 170 | 2018-04-05 | 2021-02-09 |
| Efficacy and Safety of Cytoflavin® Used in Elderly Patients for the Prevention of Cognitive Decline After Major Surgery Cytoflavin® solution, Cytoflavin® enteric-coated tablet, Placebo solution - Cognitive Dysfunction | Phase 3 | Completed | POLYSAN Scientific & Technological Pharmaceutical Company | 200 | 2017-06-02 | 2023-01-31 |
| Effect of Vitamin D3 on Lung Function and Exercise Tolerance in COPD Patients Cholecalciferol - Stable COPD Patients | Phase 1 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 48 | 2017-03-01 | 2019-01-10 |
| Mitochondrial Effects of C18:0 Supplementation in Humans C18:0, mock - Alteration of Mitochondrial Membrane, Type2 Diabetes | Not applicable | Completed | University Hospital Heidelberg | 23 | 2016-11-01 | 2017-11-27 |
| Saturated Fatty Acids and HDL Metabolism Palmitic acid, Stearic acid - Dyslipidemia | Not applicable | Completed | Maastricht University Medical Center | 41 | 2016-04-14 | 2017-08-22 |
| The Influence of Probiotics on Body Weight and Composition Probiotic, Behavioral lifestyle intervention, Placebo - Healthy, Overweight | Not applicable | Withdrawn | University of Florida | 2016-02-01 | 2016-02-09 | |
| Explorative Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting in Healthy Subjects Neurexan®, Placebo - Acute Stress Reaction | Phase 1 / Phase 2 | Completed | Biologische Heilmittel Heel GmbH | 66 | 2012-10-01 | 2015-02-11 |
| TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB Linezolid, Placebo - Multi-drug Resistant Tuberculosis, Extensively Drug Resistant Tuberculosis | Phase 1 / Phase 2 | Completed | Centers for Disease Control and Prevention | 36 | 2009-04-01 | 2026-07-06 |
| A Study to Investigate the Effect of Inhaling Single Doses of Different Formulations of GW642444M in Asthmatic Patients Placebo, GW642444, Magnesium Stearate - Pulmonary Disease, Chronic Obstructive | Phase 1 | Completed | GlaxoSmithKline | 24 | 2008-04-27 | 2017-08-10 |
COVID-19 (3) · Diabetes Mellitus, Type 2 (2) · Insulin Resistance (2) · Pulmonary Disease, Chronic Obstructive (2) · Anemia (1) · Anxiety Disorders (1) · Cognitive Dysfunction (1) · Coronavirus Infections (1) · Depression (1) · Dyslipidemias (1) · Extensively Drug-Resistant Tuberculosis (1) · Fatigue (1) · Fatigue Syndrome, Chronic (1) · Female Urogenital Diseases (1) · Hypoxia (1)
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Biologische Heilmittel Heel GmbH (1) · Centers for Disease Control and Prevention (1) · Centre de recherche du Centre hospitalier universitaire de Sherbrooke (1) · EmeraMed (1) · GlaxoSmithKline (1) · Laboratorios Viñas, S.A. (1) · Maastricht University Medical Center (1) · Mahidol University (1) · Maze Therapeutics (1) · National Center for Advancing Translational Sciences (NCATS) (1) · POLYSAN Scientific & Technological Pharmaceutical Company (1) · Trisakti University (1) · University Hospital Heidelberg (1) · University Hospital Tuebingen (1)
Germany (3) · Antarctica (1) · Australia (1) · Bangladesh (1) · Brazil (1) · Canada (1) · Colombia (1) · Indonesia (1) · Mexico (1) · Netherlands (1) · New Zealand (1) · Russia (1) · South Africa (1) · Spain (1) · Thailand (1)
Andrei C Sposito, MD.PHD (1) · Andres Cadena-Bonfanti, MD (1) · Bobbi Langkamp-Henken, PhD (1) · Christiane Laue, MD (1) · Jean-Charles Pasquier, Dr (1) · Jussi Saukkonen, MD (1) · Manfred Schedlowski, PhD (1) · Manuel Gonzalez Ortiz, MD MSc Phd (1) · Mary O'Leary (1) · Nesri Padayachin, MBChB (1) · Peter P Nawroth, MD (1) · Philip E Sanderson, PhD (1) · Pornthip Harncharoenkul, MD (1)
PMID 22870441, PMID 23131255, PMID 24515444, PMID 26772822, PMID 30774444, PMID 31073924, PMID 32043983, PMID 32143990, PMID 32346093, PMID 32534337, PMID 32612617, PMID 32678530, PMID 32900520, PMID 33231615, PMID 33332779, PMID 33649297, PMID 33733339, PMID 33870484, PMID 33993853, PMID 34373622, PMID 34632567, PMID 37405785, PMID 38214710, PMID 39329240